Safety and Efficacy Pilot Study of AzaSite® for Four Weeks in Subjects With Blepharitis

Completed · Phase 4

Conditions studied: Blepharitis

In brief

The purpose of this study is to evaluate the safety and efficacy of AzaSite® ophthalmic solution, 1% on signs and symptoms of blepharitis.

Key facts

Study ID

NCT00656539

Run by

Merck Sharp & Dohme LLC

People needed

20

Starts

2008-04-01

Last updated by the study team

2011-09-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• diagnosis of moderate to severe chronic posterior blepharitis
• If female of childbearing potential, are non-pregnant and non-lactating

You may not qualify if…

• had ocular surface surgery (LASIK, refractive, pterygium) within the past year
• unwilling to discontinue use of contact lenses during the study
• have glaucoma
• unable or unwilling to withhold the use of eyelid scrubs during the study
• have a serious systemic disease or uncontrolled medical condition that in the judgment of the investigator could confound study assessments or limit compliance
• currently using any preserved topical ocular medications (with the exception of unpreserved tear substitutes) at the time of entry into the study or during study participation

Where it is running

• Ophthalmic Consultants of Long Island — Lynbrook, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.